Email Updates
Government Resource
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).
November 3, 2015
Food and Drug Administration; FDA.
Dosing information on drug labels should be clearly articulated to prevent confusion. This announcement raises awareness of a drug strength labeling change regarding active ingredients in the antibacterial drug Zerbaxa to improve dosing accuracy.
Related Resources From the Same Author(s)
Related Resources
